Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more →
Incyte's $750M buyout rocked by pause on key trial, asset cull Read more →
Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more →
Talent to power Life Sciences
Tech talent for Life Sciences
« All Events
Dive into the cutting-edge science and innovation reshaping the future of health at the Jawdrop Summit. This year, we’re exploring how groundbreaking medical research and advancements can help keep us healthy both physically and mentally.